Related Experiment Video
Updated: Aug 15, 2026

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
Published on: January 29, 2021
[Meningeal myelomatosis. Presentation of a case]
O N Gioseffi1, G Alfonso, E Rosenfeld
1Hospital Nacional Profesor Alejandro Posadas, Servicio de Hematología, Buenos Aíres, Republica Argentina.
Abstract:
The case of a 36-year old man with IgA kappa multiple myeloma in whom meningeal myelomatosis developed is reported, and a brief review of previously published cases is made. Meningeal involvement develops in patients with high tumoral mass myeloma. Because of its poor prognosis, central nervous system chemoprophylaxis based on clinical and cerebrospinal fluid data, and systemic treatment according to severity, is suggested.
Insights
Meningeal myelomatosis, a rare complication of multiple myeloma, can occur in patients with high tumor burden. Early central nervous system chemoprophylaxis and tailored systemic treatment are recommended due to the poor prognosis.
Area of Science:
- Hematology
- Oncology
- Neurology
Background:
- Multiple myeloma is a malignant proliferation of plasma cells.
- Meningeal involvement in multiple myeloma, or meningeal myelomatosis, is a rare but serious complication.
Observation:
- This report details a case of a 36-year-old male with IgA kappa multiple myeloma who developed meningeal myelomatosis.
- A review of existing literature on meningeal myelomatosis in multiple myeloma patients was conducted.
Findings:
- Meningeal involvement is associated with a high tumoral mass in multiple myeloma.
- The condition carries a poor prognosis, necessitating prompt intervention.
Implications:
- Central nervous system chemoprophylaxis guided by clinical and cerebrospinal fluid analysis is suggested.
- Systemic treatment should be adjusted based on the severity of the disease presentation.
More Related Videos
06:25Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
Published on: March 29, 2024
07:14Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
Published on: May 23, 2025
Related Concept Videos
Viral Meningitis
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Encephalitis l: Introduction
Multiple Sclerosis l: Introduction